---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-006126"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2025-02-12T23:59:59+00:00"
generated_at: "2026-05-26T22:50:27.261316+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma raises $108K in two convertible note financings in Feb 2025

## Summary
- $65,000 convertible note (purchase price $56,000) issued Feb 6; 15% flat interest, maturity Nov 30, 2025.
- $43,000 convertible note (purchase price $40,000) issued Feb 10; 8% annual interest, maturity Oct 7, 2025.
- First note convertible at 35% discount to lowest 10-day trading price; second note at $9/share (or $6 if stock <$8 for 5 days).
- Proceeds used for general working capital; notes sold in unregistered offerings under Rule 506(b) and Section 4(a)(2).
- Both notes contain events of default including failure to pay, breach of covenants, and conversion share issuance delays.

## SEC filing metadata
- accession: 0001493152-25-006126
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2025-02-12T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000149315225006126/0001493152-25-006126-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000149315225006126/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-006126
- JSON: https://secwatch.observer/filing/0001493152-25-006126.json
- Plain text: https://secwatch.observer/filing/0001493152-25-006126.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.